Atossa Therapeutics Filed A Petition For Post Grant Review With The U.S. Patent And Trademark Office Relating To One Of The Company's Issued Patents Related To Methods For Making And Using Endoxifen
Author: Benzinga Newsdesk | August 31, 2023 06:56am